Brivaracetam

Atracurium Besylate API (CAS No: 64228-79-1) is skillfully produced at Amber Lifesciences Pvt. Ltd. in world-class GMP-compliant and ISO 9001:2015 certified manufacturing facilities, ensuring excellent purity, consistent quality, and compliance with international regulatory guidelines. Each batch is provided with a comprehensive Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), in accordance with USP/EP pharmacopeial standards.

Atracurium Besylate is a non-depolarizing neuromuscular blocking agent used as an adjunct to anesthesia for facilitating tracheal intubation and providing skeletal muscle relaxation during surgery or mechanical ventilation. It works by competitively blocking acetylcholine receptors at the neuromuscular junction. Our API is manufactured under rigorous quality control measures and validated production processes to ensure high stability and performance in pharmaceutical applications.

Amber Lifesciences caters to pharmaceutical manufacturers, formulation partners, traders, and distributors across Asia, Europe, the Middle East, and LATAM regions by providing dependable supply chains, technical expertise, and full regulatory documentation to support efficient product registration and market entry.

Storage & Transportation

Classified as non-Dangerous Goods. Store at controlled room temperature (20°C to 25°C / 68°F to 77°F), protected from moisture, light, and excessive heat. Handle as per standard pharmaceutical storage and transportation protocols.